Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells
- PMID: 10652433
- DOI: 10.1002/(sici)1097-0215(20000201)85:3<398::aid-ijc17>3.0.co;2-l
Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells
Abstract
In human gliomas, platelet-derived growth factor (PDGF) ligand and receptor mRNA are often co-expressed, which suggests the presence of an autocrine loop. To further investigate the significance of PDGF stimulation in brain tumors, we used a previously developed mouse tumor model, in which malignant brain tumors of neuroepithelial origin were induced by injecting a murine retrovirus containing the human PDGF B-chain gene into the brains of neonatal mice. In the present investigation, we have characterized a cell line established from such an experimentally induced tumor in an INK4a-/- mouse. Cultured tumor cells expressed nestin and NG2 chondroitin sulfate proteoglycan and are thus most likely derived from an oligodendrocyte precursor cell. Tumor cells produced PDGF-B protein and displayed constitutively activated PDGF alpha receptors. Autocrine receptor activation could be blocked with the specific PDGF receptor tyrosine kinase inhibitor CGP 57148B, which led to almost complete inhibition of cell proliferation, which was much less affected by a PDGF B-chain aptamer that inhibits binding of PDGF-B to PDGF receptors and is unlikely to be able to pass through the plasma membrane. Our results imply an important role for PDGF autocrine stimulation in both initiation and progression of a subtype of gliomas.
Similar articles
-
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.J Natl Cancer Inst. 2003 Mar 19;95(6):458-70. doi: 10.1093/jnci/95.6.458. J Natl Cancer Inst. 2003. PMID: 12644539
-
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437. Cancer. 2008. PMID: 18338812
-
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.Genes Dev. 2001 Aug 1;15(15):1913-25. doi: 10.1101/gad.903001. Genes Dev. 2001. PMID: 11485986 Free PMC article.
-
Platelet-derived growth factor in human glioma.Glia. 1995 Nov;15(3):257-63. doi: 10.1002/glia.440150307. Glia. 1995. PMID: 8586462 Review.
-
Platelet-derived growth factor receptors: a therapeutic target in solid tumors.Semin Oncol. 2001 Oct;28(5 Suppl 17):27-33. Semin Oncol. 2001. PMID: 11740804 Review.
Cited by
-
Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination.Neuron. 2010 Mar 11;65(5):597-611. doi: 10.1016/j.neuron.2010.01.027. Neuron. 2010. PMID: 20223197 Free PMC article.
-
A role for the NG2 proteoglycan in glioma progression.Cell Adh Migr. 2008 Jul-Sep;2(3):192-201. doi: 10.4161/cam.2.3.6279. Epub 2008 Jul 13. Cell Adh Migr. 2008. PMID: 19262111 Free PMC article. Review.
-
Roles of NG2 glial cells in diseases of the central nervous system.Neurosci Bull. 2011 Dec;27(6):413-21. doi: 10.1007/s12264-011-1838-2. Neurosci Bull. 2011. PMID: 22108818 Free PMC article. Review.
-
PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.BMC Cancer. 2010 Oct 12;10:550. doi: 10.1186/1471-2407-10-550. BMC Cancer. 2010. PMID: 20939912 Free PMC article.
-
The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.Int J Mol Sci. 2018 Sep 12;19(9):2724. doi: 10.3390/ijms19092724. Int J Mol Sci. 2018. PMID: 30213051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases